EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells

Journal of Clinical Investigation

Volumn 99, Issue 2, 1997, Pages 239-247

  Tanaka, Kazuhiro ^a,b   Iwakuma, Tomoo ^a   Harimaya, Katsumi ^a   Sato, Hideshi ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

cell cycle; chromosomal translocation; competitive polymerase chain reaction; gene therapy; small round cell tumors

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY DNA; GENE PRODUCT; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 22; CONTROLLED STUDY; EWING SARCOMA; FEMALE; GENE EXPRESSION; GENE FUSION; HUMAN; HUMAN CELL; MOUSE; NEUROECTODERM TUMOR; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031025207     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119152     Document Type: Article

References (58)

1. Rabbitts, T.H. 1994. Chromosomal translocations in human cancer. Nature (Lond.). 372:143-149.
2. Sreekantaiah, C., M. Ladanyi, E. Rodriguez, and R.S.K. Chaganti. 1994. Chromosomal aberrations in soft tissue tumors. Am. J. Pathol. 144:1121-1134.
3. Delattre, O., J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P.D. Jong, G. Rouleau, A. Aurias, and G. Thomas. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature (Lond.). 359:162-165.
4. Crozat, A., P. Aman, N. Mandahl, and D. Ron. 1993. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (Lond.). 363:640-644.
5. Rabbitts, T.H., A. Forster, R. Larson, and P. Nathan. 1993. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet. 4:175-180.
6. Barr, F.G., N. Galili, J. Holick, J.A. Biegel, G. Rovera, and B.S. Emanuel. 1993. Rearrangement of the PAX3 paired box gene in the pediatric solid tumor alveolar rhabdomyosarcoma. Nat. Genet. 3:113-117.
7. Galili, N., R.J. Davis, W.J. Fredericks, S. Mukhopadhyay, F.J. Rauscher III, B.S. Emanuel, G. Rovera, and F.G. Barr. 1993. Fusion of a fork head domain gene to PAX3 in the solid tumor alveolar rhabdomyosarcoma. Nat. Genet. 5:230-235.
8. Clark, J., P.J. Rocques, A.J. Crew, S. Gill, J. Shipley, A.M. Chan, B.A. Gusterson, and C.S. Cooper. 1994. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat. Genet. 7:502-508.
9. Turc-Carel, C., I. Philip, M.P. Berger, T. Philip, and G.M. Lanoir. 1983. Chromosomal translocations in Ewing's sarcoma. N. Engl. J. Med. 309:497-498.
10. Whang-Peng, J., T.J. Triche, T. Knutsen, J. Miser, E.C. Douglass, and M.A. Israel. 1984. Chromosomal translocations in peripheral neuroepithelioma. N. Engl. J. Med. 311:584-585.
11. Whang-Peng, J., T.J. Triche, T. Knutsen, J. Miser, S. Kao-Shan, S. Tsai, and M. A. Israel. 1986. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet. Cytogenet. 21:185-208.
12. Zhang, L., V. Lemarchandel, P.H. Romeo, Y. Ben-David, P. Greer, and A. Bernstein. 1993. The FLI-1 protooncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene. 8:1621-1630.
13. May, W.A., M.L. Gishizky, S.L. Lessnick, L.B. Lunsford, B.C. Lewis, O. Delattre, J. Zucman, G. Thomas, and C.T. Denny. 1993. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that require the DNA-binding domain encoded by FLII for transformation. Proc. Natl. Acad. Sci. USA. 90:5752-5756.
14. May, W.A., S.L. Lessnick, B.S. Braun, M. Klemsz, B.C. Lewis, L.B. Lunsford, R. Hromas, and C.T. Denny. 1993. The Ewing sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13:7393-7398.
15. Ohno, T., V.N. Rao, and E.S. Reddy. 1993. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res. 53:5859-5863.
16. Bailly, R.A., R. Bosselut, J. Zucman, F. Cormier, O. Delattre, M. Roussel, G. Thomas, and J. Ghysdael. 1994. DNA-binding and transcriptional activation of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14:3230-3241.
17. Mao, X., S. Miesfeldt, H. Yang, J.M. Leiden, and C.B. Thompson. 1994. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J. Biol. Chem. 269:18216-18222.
18. Braun, B.S., R. Frieden, S.L. Lessnick, W.A. May, and C.T. Denny. 1995. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol. Cell. Biol. 15:4623-4630.
19. Ouchida, M., T. Ohno, Y. Fujimura, V.N. Rao, and E.S.P. Reddy. 1995. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene. 11:1049-1054.
20. Kovar, H., D.N.T. Aryee, G. Jug, C. Henoecki, M. Schemper, O. Delattre, G. Thomas, and H. Gadner. 1996. EWS/FLI1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ. 7:429-437.
21. Crooke, S.T. 1993. Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J. 7:533-539.
22. Stein, C.A., and Y.C. Cheng. 1993. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science (Wash. DC). 261:1004-1012.
23. Haeuptle, M., R. Frank, and B. Dobberstein. 1986. Translation arrest by oligodeoxynucleotides complementary to mRNA coding sequences yields polypeptides of predetermined length. Nucleic Acid Res. 14:1427-1448.
24. Walder, R.Y., and J.A. Walder. 1988. Role of RNase H in hybrid-arrested translation by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA. 85:5011-5015.
25. Munroe, S.H. 1988. Antisense RNA inhibits splicing of pre-mRNA in vitro. EMBO (Eur. Mol. Biol. Organ.) J. 7:2523-2532.
26. Tanaka, K., Y. Iwamoto, Y. Noguchi, Y. Oda, and Y. Sugioka. 1995. Establishment and characterization of a peripheral neuroepithelioma cell line in soft tissue of extremity. Lab. Invest. 72:237-248.
27. Chen, G., J.P. Jaffrezou, W.H. Fleming, G.E. Duran, and B.I. Sikic. 1994. Prevalence of multidrug resistance related to activation of the mdr-1 gene in human sarcoma mutants derived by single-step doxorubicin selection. Cancer Res. 54:4980-4987.
28. Tanaka, K., Y. Iwamoto, Y. Ito, T. Ishibashi, Y. Nakabeppu, M. Sekiguchi, and Y. Sugioka. 1995. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res. 55:2927-2935.
29. Wilhelm, S.M., I.E. Collier, B.L. Marmer, A.Z. Eisen, G.A. Grant, and G.I. Goldberg. 1989. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:17213-17221.
30. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Measurement of radioactivity in nucleic acids. In Molecular Cloning: A Laboratory Manual. C. Noran, editor. Cold Spring Harbor Press, New York. E.18-E.19.
31. Nakabeppu, Y., S. Oda, and M. Sekiguchi. 1993. Proliferative activation of quiescent Rat-1A cells by DFosB. Mol. Cell. Biol. 13:4157-4166.
32. Giovannini, M., J.A. Biegel, M. Serra, J.Y. Wang, Y.H. Wei, L. Nycum, B.S. Emanuel, and G.A. Evans. 1994. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. J. Clin. Invest. 94:489-496.
33. Ewing, J. 1921. Diffuse endothelioma of bone. Proc. NY Pathol. Soc. 21: 17-24.
34. Stout, A.P. 1918. A tumor of an ulnar nerve. Proc. NY Pathol. Soc. 18:2-12.
35. Thiele, C.J., C. McKeon, T.J. Triche, R.A. Ross, C.P. Reynolds, and M.A. Israel. 1987. Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J. Clin. Invest. 80:804-811.
36. McKeon, C., C.J. Thiele, R.A. Ross, M. Kwan, T.J .Triche, J.S. Miser, and M.A. Israel. 1988. Indistinguishable patterns of proto-oncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Res. 48:4307-4311.
37. Cavazzana, A.O., J.S. Miser, J. Jefferson, and T.J. Triche. 1987. Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am. J. Pathol. 127:507-518.
38. Noguera, R., T.J. Triche, S. Navarro, M. Tsokos, and A. Llombart-Bosch. 1992. Dynamic model of differentiation in Ewing's sarcoma cells: comparative analysis of morphologic, immunocytochemical, and oncogene expression parameters. Lab. Invest. 62:143-151.
39. Wang, A.M., M.V. Doyle, and D.F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:9717-9721.
40. Gilliland, G., S. Perrin, K. Blanchard, and H.F. Bunn. 1990. Analysis of cytokines DNA and RNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 87:2725-2729.
41. Siebert, P.D., and J.W. Larrick. 1992. Competitive PCR. Nature (Lond.). 259:557-558.
42. Peten, E.P., L.J. Striker, M.A. Carome, S.J. Elliott, C.W. Yang, and G.E. Striker. 1992. The contribution of increased collagen synthesis to human glomerulosclerosis: a quantitative analysis of a2IV collagen mRNA expression by competitive polymerase chain reaction. J. Exp. Med. 176:1571-1576.
43. Delattre, O., J. Zucman, T. Melot, X.S. Garau, J.M. Zucker, G.M. Lenoir, P.P. Ambros, D. Sheer, C. Turc-Carel, T.J. Triche et al. 1994. The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N. Engl. J. Med. 331:294-299.
44. Sorensen, P.H., S.L. Lessnick, D. Lopez-Terrada, X.F. Liu, T.J. Triche, and C.T. Denny. 1994. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Natl. Genet. 6: 146-151.
45. Jeon, I., J.N. Davis, B.S. Braun, J.E. Sublett, M.F. Roussel, C.T. Denny, and D.N. Shapiro. 1995. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 10:1229-1234.
46. Zucman, J., O. Delattre, C. Desmaze, A.L. Epstein, G. Stenman, F. Speleman, C.D. Fletchers, A. Aurias, and G. Thomas. 1993. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat. Genet. 4:341-345.
47. Ladanyi, M., and W. Gerald. 1994. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 54:2837-2840.
48. Herschman, H.R. 1991. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60:281-319.
49. Lau, L.F., and D. Nathans. 1991. Genes induced by serum growth factors. In Molecular Aspects of Cellular Regulation. Vol. 6. P. Cohen and J.G. Foulkes, editors. Elsevier Science, Amsterdam, Netherlands. 257-293.
50. Nathans, D., B.A. Christy, R. DuBois, A. Lanahan, L. Sanders, and Y. Nakabeppu. 1991. Transcriptional factors induced by growth-signaling agents. In Origins of Human Cancers: A Comprehensive Review. J. Brugge, T. Curran, E. Harlow, and F. McCormick, editors. Cold Spring Harbor Press, New York. 353-364.
51. Ransone, L.J., and I.M. Verma. 1990. Nuclear protooncogenes Fos and Jun. Annu. Rev. Cell Biol. 6:539-557.
52. Kretzner, L., E.M. Blackwood, and R. Eisenman. 1992. Myc and Max protein possess distinct transcriptional activities. Nature (Lond.). 359:426-429.
53. Langer, S.L., D.M. Bortner, M.F. Roussel, C.J. Sherr, and M.C. Ostrowski. 1992. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol. Cell. Biol. 12:5355-5362.
54. Roussel, M.F., J.N. Davis, J.L. Cleveland, J. Ghysdael, and S.W. Hiebert. 1994. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F1. Oncogene. 9:405-415.
55. Burdach, S., H. Jurgens, C. Peters, W. Nurnberger, C. Mauz-Korholz, D. Korholz, M. Paulussen, H. Pape, D. Dilloo, E. Koscielniak et al. 1993. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J. Clin. Oncol. 11:1482-1488.
56. Frassica, F.J., D.A. Frassica, D.J. Pritchard, P.J. Schomberg, L.E. Wold, and F.H. Sim. 1993. Ewing sarcoma of the pelvis. Clinicopathological features and treatment. J. Bone Joint Surg. Am. Vol. 75:1457-1465.
57. Maygarden, S.J., F.B. Askin, G.P. Siegal, L.A. Gilula, J. Schoppe, M. Foulkes, J.M. Kissane, and M. Nesbit. 1993. Ewing sarcoma of bone in infants and toddlers. A clinicopathologic report from the Intergroup Ewing's Study. Cancer. 71:2109-2118.
58. Ladenstein, R., C. Lasset, R. Pinketon, J.M. Zucker, C. Peters, S. Burdach, N. Pardo, G. Dollorso, C. Coze, M. Buclon et al. 1995. Impact of mega-therapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumor Registry. Bone Marrow Transplant. 15:697-705.